Annual Working Capital
$15.13 M
-$1.40 M-8.45%
December 31, 2022
Summary
- As of February 10, 2025, NVIV annual working capital is $15.13 million, with the most recent change of -$1.40 million (-8.45%) on December 31, 2022.
- During the last 3 years, NVIV annual working capital has risen by +$11.01 million (+267.31%).
Performance
NVIV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$8.86 M
-$2.28 M-20.45%
September 30, 2023
Summary
- As of February 10, 2025, NVIV quarterly working capital is $8.86 million, with the most recent change of -$2.28 million (-20.45%) on September 30, 2023.
- Over the past year, NVIV quarterly working capital has dropped by -$199.00 thousand (-2.20%).
Performance
NVIV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NVIV Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | -2.2% |
| 3 y3 years | +267.3% | +40.2% |
| 5 y5 years | +41.5% | -49.1% |
NVIV Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.5% | at low | -46.4% | at low |
| 5 y | 5-year | -14.4% | -72.8% | -63.2% | -53.5% |
| alltime | all time | -47.8% | -309.6% | -78.9% | -458.1% |
InVivo Therapeutics Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $8.86 M(-20.4%) |
| Jun 2023 | - | $11.14 M(-14.0%) |
| Mar 2023 | - | $12.96 M(-14.4%) |
| Dec 2022 | $15.13 M(-8.5%) | $15.13 M(+67.1%) |
| Sep 2022 | - | $9.06 M(-18.9%) |
| Jun 2022 | - | $11.17 M(-19.7%) |
| Mar 2022 | - | $13.92 M(-15.8%) |
| Dec 2021 | $16.53 M(-6.5%) | $16.53 M(-14.7%) |
| Sep 2021 | - | $19.38 M(-10.9%) |
| Jun 2021 | - | $21.76 M(-9.5%) |
| Mar 2021 | - | $24.04 M(+36.0%) |
| Dec 2020 | $17.68 M(+329.2%) | $17.68 M(+179.9%) |
| Sep 2020 | - | $6.32 M(-26.1%) |
| Jun 2020 | - | $8.55 M(+5.5%) |
| Mar 2020 | - | $8.10 M(+96.6%) |
| Dec 2019 | $4.12 M(-72.4%) | $4.12 M(-35.6%) |
| Sep 2019 | - | $6.40 M(-28.9%) |
| Jun 2019 | - | $9.00 M(-26.4%) |
| Mar 2019 | - | $12.24 M(-18.0%) |
| Dec 2018 | $14.92 M(+39.5%) | $14.92 M(-14.3%) |
| Sep 2018 | - | $17.41 M(-912.8%) |
| Jun 2018 | - | -$2.14 M(-123.7%) |
| Mar 2018 | - | $9.04 M(-15.5%) |
| Dec 2017 | $10.69 M(-63.1%) | $10.69 M(-25.9%) |
| Sep 2017 | - | $14.44 M(-24.0%) |
| Jun 2017 | - | $18.98 M(-18.5%) |
| Mar 2017 | - | $23.28 M(-19.7%) |
| Dec 2016 | $29.00 M(+66.4%) | $29.00 M(-11.9%) |
| Sep 2016 | - | $32.93 M(-13.4%) |
| Jun 2016 | - | $38.05 M(-9.3%) |
| Mar 2016 | - | $41.96 M(+140.8%) |
| Dec 2015 | $17.43 M(+182.5%) | $17.43 M(+1.1%) |
| Sep 2015 | - | $17.23 M(+11.0%) |
| Jun 2015 | - | $15.53 M(+50.8%) |
| Mar 2015 | - | $10.30 M(+66.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $6.17 M(-50.0%) | $6.17 M(-54.4%) |
| Sep 2014 | - | $13.53 M(-2.1%) |
| Jun 2014 | - | $13.82 M(+59.8%) |
| Mar 2014 | - | $8.65 M(-29.9%) |
| Dec 2013 | $12.33 M(-482.9%) | $12.33 M(-27.3%) |
| Sep 2013 | - | $16.96 M(-21.1%) |
| Jun 2013 | - | $21.50 M(-240.8%) |
| Mar 2013 | - | -$15.27 M(+374.0%) |
| Dec 2012 | -$3.22 M(-89.8%) | -$3.22 M(-193.0%) |
| Sep 2012 | - | $3.46 M(-164.4%) |
| Jun 2012 | - | -$5.38 M(-40.6%) |
| Mar 2012 | - | -$9.04 M(-71.5%) |
| Dec 2011 | -$31.72 M(+1351.1%) | -$31.72 M(+2749.6%) |
| Sep 2011 | - | -$1.11 M(-75.4%) |
| Jun 2011 | - | -$4.53 M(+29.0%) |
| Mar 2011 | - | -$3.52 M(+3926.8%) |
| Dec 2010 | -$2.19 M(+9323.7%) | - |
| Sep 2010 | - | -$87.30 K(+41.0%) |
| Jun 2010 | - | -$61.90 K(+166.8%) |
| Mar 2010 | - | -$23.20 K(+41.5%) |
| Mar 2010 | -$23.20 K(-50.7%) | - |
| Dec 2009 | - | -$16.40 K(+59.2%) |
| Sep 2009 | - | -$10.30 K(+543.8%) |
| Jun 2009 | - | -$1600.00(-96.6%) |
| Mar 2009 | -$47.10 K(-370.7%) | -$47.10 K(+412.0%) |
| Dec 2008 | - | -$9200.00(+53.3%) |
| Sep 2008 | - | -$6000.00(+106.9%) |
| Jun 2008 | - | -$2900.00(-116.7%) |
| Mar 2008 | $17.40 K(+461.3%) | $17.40 K(-376.2%) |
| Dec 2007 | - | -$6300.00(-1675.0%) |
| Sep 2007 | - | $400.00(-136.4%) |
| Jun 2007 | - | -$1100.00(-135.5%) |
| Mar 2007 | $3100.00(-97.7%) | $3100.00(-85.5%) |
| Dec 2006 | - | $21.40 K(-62.0%) |
| Sep 2006 | - | $56.30 K(-58.6%) |
| Mar 2006 | $136.10 K | $136.10 K |
FAQ
- What is InVivo Therapeutics Holdings annual working capital?
- What is the all time high annual working capital for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual working capital year-on-year change?
- What is InVivo Therapeutics Holdings quarterly working capital?
- What is the all time high quarterly working capital for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly working capital year-on-year change?
What is InVivo Therapeutics Holdings annual working capital?
The current annual working capital of NVIV is $15.13 M
What is the all time high annual working capital for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual working capital is $29.00 M
What is InVivo Therapeutics Holdings annual working capital year-on-year change?
Over the past year, NVIV annual working capital has changed by -$1.40 M (-8.45%)
What is InVivo Therapeutics Holdings quarterly working capital?
The current quarterly working capital of NVIV is $8.86 M
What is the all time high quarterly working capital for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly working capital is $41.96 M
What is InVivo Therapeutics Holdings quarterly working capital year-on-year change?
Over the past year, NVIV quarterly working capital has changed by -$199.00 K (-2.20%)